Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515603
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515603
Cancer Cachexia Market, By Therapeutics, By Mechanism of Action, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 288 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Cancer Cachexia Market size was valued at USD 3,228.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.
Cancer cachexia presents as a multifaceted metabolic syndrome frequently observed in patients with advanced stages of malignancy. Characterized by involuntary weight loss, skeletal muscle wasting, fatigue, and anorexia, this syndrome transcends the limitations of inadequate dietary intake. Underlying mechanisms encompass systemic inflammation, metabolic aberrations, and the host's response to tumor-derived factors. Despite advancements in oncological therapies, cancer cachexia remains a formidable challenge, significantly impacting both the treatment outcomes and quality of life for affected individuals.
Cancer Cachexia Market- Market Dynamics
Rising cancer burden to propel market demand
The global cancer burden is rising, necessitating the modification of cancer therapies according to national and regional priorities. According to the (IARC) International Agency for Research on Cancer in December 2020, 1 in 5 people globally will develop cancer during their lifetime, with 1 in 11 women and 1 in 8 men dying from the disease. Data from the WHO, published in February 2022, indicates that approximately 400,000 children develop cancer annually, with the most common types varying by country. For instance, cervical cancer is the most prevalent in 23 countries. The increasing global cancer burden also raises the prevalence of cancer cachexia, characterized by negative protein and energy balance, systemic inflammation, and involuntary loss of lean body mass. The growing prevalence of cancer cachexia, and cancer along with increased investment in R&D for novel cancer cachexia treatments, are major factors driving market growth.
Cancer Cachexia Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)
Based on Therapeutics segmentation, progestogens were predicted to show maximum market share in the year 2023
Based on the mechanism of action segmentation, appetite stimulators were the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Cancer Cachexia Market- Segmentation Analysis:
The Global Cancer Cachexia Market is broadly segmented on the basis of Therapeutics, Mechanism of Action, Application, and Region.
The market is divided into four categories based on Therapeutics: progestogens, corticosteroids, combination therapies, and others. The progestogens segment held a dominant market share in 2023, due to their lower cost and high efficiency in treating cancer cachexia.
The market is broadly divided into two categories based on mechanism of action: Appetite Stimulators and Weight Loss Stabilizers. By mechanism of action, appetite stimulators are expected to dominate and grow significantly in the cancer cachexia market. Cancer patients often experience sort of appetite loss and unintended weight loss, which are linked to decreased performance status, reduced response and tolerance to treatment, decreased survival, and diminished quality of life. Therefore, the use of appetite stimulants is increasingly considered for patients with reduced appetite. The rising prevalence of cancer cachexia is a major factor driving the market's growth.
Cancer Cachexia Market- Geographical Insights
From a geographical perspective, this market extends across Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the participating nations. North America is expected to lead the market, driven by the high burden of cancer and cancer cachexia, the presence of numerous drug manufacturers, and advancements in cancer patient care. According to GLOBOCAN 2020 estimates, Mexico reported around 195,499 new cancer cases. Additionally, the American Cancer Society projected approximately 1.9 million new cancer cases would be diagnosed in the United States in 2022.
Cancer Cachexia Market- Competitive Landscape:
The cancer cachexia market is consolidated, with only a few major companies operating globally and regionally. These key players are primarily focused on R&D to develop highly effective novel drugs for treating cancer cachexia, resulting in a growing pipeline of therapeutics awaiting approval and commercial launch. As of October 2022, clinicaltrials.gov reported 150 studies either conducted or ongoing to develop drugs for cancer cachexia. For instance, in December 2020, the University of Copenhagen, in collaboration with Zealand University Hospital, initiated a study to monitor the effect of the medical cannabidiol on the lean body mass (cachexia) in patients receiving Oxaliplatin- or Paclitaxel-based chemotherapy.
Recent Developments:
In January 2021, Helsinn Group and Ono Pharmaceutical Co. Ltd received approval in Japan to manufacture and market Adlumiz, a ghrelin receptor agonist for treating cancer cachexia in the patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Therefore, increasing research and development activities in the field are expected to drive market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER CACHEXIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Aeterna Zentaris
Aphios Corporation
Bristol-Myers Squibb Company
Pfizer Inc.
Helsinn Group
Merck KGaA
Artelo Biosciences Inc.
NGM Biopharmaceuticals
Aveo Oncology
Aavogen Inc.
Green Cross Wellbeing Corporation
Cannabics Pharmaceuticals Inc.
TCI Peptide Therapeutics
Fresenius Kabi
Tetra Bio-Pharma
Actimed Therapeutics
Others
GLOBAL CANCER CACHEXIA MARKET, BY THERAPEUTICS - MARKET ANALYSIS, 2019 - 2032
- Progestogens
- Corticosteroids
- Combination Therapy
- Other Therapeutics
GLOBAL CANCER CACHEXIA MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032
- Appetite Stimulators
- Weight Loss Stabilizers
GLOBAL CANCER CACHEXIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
GLOBAL CANCER CACHEXIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV3357
Table of Contents
1. Cancer Cachexia Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Cancer Cachexia Market Snippet by Therapeutics
- 2.1.2. Cancer Cachexia Market Snippet by Mechanism of Action
- 2.1.3. Cancer Cachexia Market Snippet by Application
- 2.1.4. Cancer Cachexia Market Snippet by Country
- 2.1.5. Cancer Cachexia Market Snippet by Region
- 2.2. Competitive Insights
3. Cancer Cachexia Key Market Trends
- 3.1. Cancer Cachexia Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Cancer Cachexia Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Cancer Cachexia Market Opportunities
- 3.4. Cancer Cachexia Market Future Trends
4. Cancer Cachexia Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Cancer Cachexia Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Cancer Cachexia Market Landscape
- 6.1. Cancer Cachexia Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Cancer Cachexia Market - By Therapeutics
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutics, 2023 & 2032 (%)
- 7.1.2. Progestogens
- 7.1.3. Corticosteroids
- 7.1.4. Combination Therapy
- 7.1.5. Other Therapeutics
8. Cancer Cachexia Market - By Mechanism of Action
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
- 8.1.2. Appetite Stimulators
- 8.1.3. Weight Loss Stabilizers
9. Cancer Cachexia Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacy
- 9.1.3. Retail Pharmacy
- 9.1.4. Online Pharmacy
10. Cancer Cachexia Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Cancer Cachexia Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cancer Cachexia Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cancer Cachexia Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cancer Cachexia Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cancer Cachexia Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Cancer Cachexia Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Aeterna Zentaris
- 11.2.2. Aphios Corporation
- 11.2.3. Bristol-Myers Squibb Company
- 11.2.4. Pfizer Inc.
- 11.2.5. Helsinn Group
- 11.2.6. Merck KGaA
- 11.2.7. Artelo Biosciences Inc.
- 11.2.8. NGM Biopharmaceuticals
- 11.2.9. Aveo Oncology
- 11.2.10. Aavogen Inc.
- 11.2.11. Green Cross Wellbeing Corporation
- 11.2.12. Cannabics Pharmaceuticals Inc.
- 11.2.13. TCI Peptide Therapeutics
- 11.2.14. Fresenius Kabi
- 11.2.15. Tetra Bio-Pharma
- 11.2.16. Actimed Therapeutics
- 11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV3357
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Cancer Cachexia Market: Therapeutics Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Therapeutics
- TABLE Global Cancer Cachexia Market, by Therapeutics 2019-2032 (USD Million)
- TABLE Cancer Cachexia Market: Mechanism of Action Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Mechanism of Action
- TABLE Global Cancer Cachexia Market, by Mechanism of Action 2019-2032 (USD Million)
- TABLE Cancer Cachexia Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Cancer Cachexia Market, by Application 2019-2032 (USD Million)
- TABLE Cancer Cachexia Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Cancer Cachexia Market, by Region 2019-2032 (USD Million)
- TABLE North America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
- TABLE North America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
- TABLE North America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
- TABLE North America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
- TABLE Europe Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
- TABLE Europe Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
- TABLE Europe Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
- TABLE Asia Pacific Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
- TABLE Asia Pacific Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
- TABLE Latin America Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
- TABLE Latin America Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa Cancer Cachexia Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Million)
- TABLE Middle East and Africa Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Million)
- TABLE Middle East and Africa Cancer Cachexia Market, by Application, 2019-2032 (USD Million)
List of Figures
- FIGURE Cancer Cachexia Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Therapeutics segment market share analysis, 2023 & 2032
- FIGURE Therapeutics segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mechanism of Action segment market share analysis, 2023 & 2032
- FIGURE Mechanism of Action segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Application segment market share analysis, 2023 & 2032
- FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Cancer Cachexia Market share and leading players, 2023
- FIGURE Europe Cancer Cachexia Market share and leading players, 2023
- FIGURE Asia Pacific Cancer Cachexia Market share and leading players, 2023
- FIGURE Latin America Cancer Cachexia Market share and leading players, 2023
- FIGURE Middle East and Africa Cancer Cachexia Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Cancer Cachexia Market share analysis by country, 2023
- FIGURE Germany Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Cancer Cachexia Market share analysis by country, 2023
- FIGURE India Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Cancer Cachexia Market share analysis by country, 2023
- FIGURE Brazil Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Cancer Cachexia Market share analysis by country, 2023
- FIGURE Saudi Arabia Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Cancer Cachexia Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.